BRAF and neoplasm: Inconsistently, NRAS and BRAF in the context of oncogenic, which gain new and tumour-related cellular functions because of nucleotide mutations, MITF turn into oncogenic by deregulating, impacting survival systems that are also described in the general melanocyte lineage.